327 related articles for article (PubMed ID: 21071687)
1. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
[TBL] [Abstract][Full Text] [Related]
3. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
4. A prospective, population-based study of low density lipoprotein particle size as a risk factor for ischemic heart disease in men.
Lamarche B; St-Pierre AC; Ruel IL; Cantin B; Dagenais GR; Després JP
Can J Cardiol; 2001 Aug; 17(8):859-65. PubMed ID: 11521128
[TBL] [Abstract][Full Text] [Related]
5. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
6. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism at the TRIB1 gene modulates plasma lipid levels: insight from the Spanish familial hypercholesterolemia cohort study.
Garcia-Rios A; Perez-Martinez P; Mata P; Fuentes F; Lopez-Miranda J; Alonso R; Caballero J; Mata N; Perez-Jimenez F; Ordovas JM
Nutr Metab Cardiovasc Dis; 2011 Dec; 21(12):957-63. PubMed ID: 20692138
[TBL] [Abstract][Full Text] [Related]
8. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
[TBL] [Abstract][Full Text] [Related]
10. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women.
Nordestgaard BG; Benn M; Schnohr P; Tybjaerg-Hansen A
JAMA; 2007 Jul; 298(3):299-308. PubMed ID: 17635890
[TBL] [Abstract][Full Text] [Related]
11. Hereditary hemochromatosis and risk of ischemic heart disease: a prospective study and a case-control study.
Ellervik C; Tybjaerg-Hansen A; Grande P; Appleyard M; Nordestgaard BG
Circulation; 2005 Jul; 112(2):185-93. PubMed ID: 15998685
[TBL] [Abstract][Full Text] [Related]
12. [Association of MK2 gene polymorphisms with low-density lipoprotein cholesterol and tumor necrosis factor-alpha in Uygur population from Hetian area of Xinjiang].
Lin N; Li NF; Yao XG; Wang HM; Liang DP; Guo YY; Zhou L
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Feb; 35(1):52-7. PubMed ID: 23469791
[TBL] [Abstract][Full Text] [Related]
13. Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles.
Yoshida T; Yajima K; Hibino T; Kato K; Matsuo H; Segawa T; Watanabe S; Oguri M; Yokoi K; Nozawa Y; Kimura G; Yamada Y
Int J Mol Med; 2007 Oct; 20(4):581-90. PubMed ID: 17786291
[TBL] [Abstract][Full Text] [Related]
14. Nonfasting cholesterol and triglycerides and association with risk of myocardial infarction and total mortality: the Copenhagen City Heart Study with 31 years of follow-up.
Langsted A; Freiberg JJ; Tybjaerg-Hansen A; Schnohr P; Jensen GB; Nordestgaard BG
J Intern Med; 2011 Jul; 270(1):65-75. PubMed ID: 21198993
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme gene polymorphism, lipids, and apolipoproteins in menopausal women on hormone replacement therapy.
Cubrilo-Turek M; Sertić J; Duraković Z
Acta Med Croatica; 2001; 55(4-5):161-7. PubMed ID: 12398019
[TBL] [Abstract][Full Text] [Related]
16. [Alcohol consumption, S-LDL-cholesterol and risk of ischemic heart disease. 6-year follow-up in The Copenhagen Male Study].
Hein HO; Suadicani P; Gyntelberg F
Ugeskr Laeger; 1997 Jun; 159(26):4110-6. PubMed ID: 9229869
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive treatment, high triglycerides, and low high-density lipoprotein cholesterol and risk of ischemic heart disease mortality: a 16-year follow-up in the Copenhagen male study.
Suadicani P; Hein HO; Gyntelberg F
Metab Syndr Relat Disord; 2010 Jun; 8(3):215-22. PubMed ID: 20156073
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein profile and prevalence of cardiovascular risk factors in urban Moroccan women.
El ayachi M; Mziwira M; Vincent S; Defoort C; Portugal H; Lairon D; Belahsen R
Eur J Clin Nutr; 2005 Dec; 59(12):1379-86. PubMed ID: 16118656
[TBL] [Abstract][Full Text] [Related]
19. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
Langsted A; Freiberg JJ; Nordestgaard BG
Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
[TBL] [Abstract][Full Text] [Related]
20. Genetic inhibition of CETP, ischemic vascular disease and mortality, and possible adverse effects.
Johannsen TH; Frikke-Schmidt R; Schou J; Nordestgaard BG; Tybjærg-Hansen A
J Am Coll Cardiol; 2012 Nov; 60(20):2041-8. PubMed ID: 23083790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]